检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:李宗睿 刘为朋 胡宝光[1] Li Zongrui;Liu Weipeng;Hu Baoguang(Department of Gastrointestinal Surgery,Binzhou Medical University Hospital,Binzhou 256600,China)
机构地区:[1]滨州医学院附属医院胃肠外科,滨州256600
出 处:《国际医药卫生导报》2023年第20期2852-2856,共5页International Medicine and Health Guidance News
基 金:山东省自然科学基金(ZR2017LHO50)。
摘 要:自然杀伤细胞2D(natural killer cell 2D,NKG2D)及其配体在NK细胞识别、启动、增强或抑制淋巴细胞效应功能上发挥着重要作用。近年来,随着肿瘤免疫逃避研究的深入,NK细胞上的NKG2D受体成为一个研究热门。胃癌作为严重影响人类寿命的疾病,其治疗一直是难以突破的难题。近年来,针对癌症的免疫治疗取得了重大突破。NKG2D及其配体可能是一个潜在的免疫治疗方向,故本文综述了NKG2D及其配体治疗胃癌的研究进展。Natural killer cell 2D(NKG2D)and its ligands play an important role in the recognition,initiation,enhancement,or inhibition of lymphocyte effects in NK cells.In recent years,the NKG2D receptor on NK cells has become a hot research topic with the deepening of tumor immune evasion research.As a serious disease affecting human life span,gastric cancer's treatment has been a difficult problem.In recent years,major breakthroughs have been made in the immunotherapy of cancer.NKG2D and its ligands may be a potential direction of immunotherapy.Therefore,this paper reviews the research progress of NKG2D and its ligands in the treatment of gastric cancer.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.33